212-681-1575
Sep

26

New Mesothelioma Clinical Trial Offers Latest Brea...

Posted by

Label: Featured News


Immunotherapy treatment for mesothelioma patients has taken off over the last year with the U.S. Food and Drug Administration's recent approval of Opdivo and Keytruda, both effective in the fight against lung cancer. Survival has increased in mesothelioma patients treated with immunotherapy. Now, researchers hope to boost survival rates even higher by incorporating surgery with immunotherapy in mesothelioma patients. Baylor College of Medicine oncologists have launched the first in-human study of treatment with a checkpoint inhibitor immunotherapy followed by surgery in patients suffering from malignant pleural mesothelioma, according to a Sept. 6 press release from Read Full Story

Want Specific topic updates?